QURIENT CO LTD has a total of 45 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are EIGER GROUP INT INC, STEHLIN FOUNDATION FOR CANCER and ESANEX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Singapore | 5 | |
#5 | Republic of Korea | 4 | |
#6 | United States | 4 | |
#7 | China | 3 | |
#8 | Australia | 2 | |
#9 | Hong Kong | 2 | |
#10 | Hungary | 2 | |
#11 | Philippines | 2 | |
#12 | Brazil | 1 | |
#13 | Israel | 1 | |
#14 | Japan | 1 | |
#15 | Mexico | 1 | |
#16 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kim Jaeseung | 24 |
#2 | Nam Kiyean | 23 |
#3 | Jeon Yeejin | 22 |
#4 | Park Dongsik | 21 |
#5 | Nam Ki Yean | 11 |
#6 | Ahn Ji Ye | 11 |
#7 | Lee Sae Yeon | 11 |
#8 | Kim Jeong Jun | 11 |
#9 | Yu Donghoon | 10 |
#10 | Seo Mooyoung | 10 |
Publication | Filing date | Title |
---|---|---|
WO2021018387A1 | Different forms of 6-chloro-2-ethyl-n-(4-(4-(4-(trifluoromethoxy)phenyl)piperidine-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamide | |
EP3774776A1 | Quinoline derivatives as inhibitors of axl/mer rtk and csf1r | |
CA3095880A1 | Pyrazolo-triazine and/or pyrazolo-pyrimidine derivatives as selective inhibitor of cyclin dependent kinase | |
SG11202009466UA | Pharmaceutically active pyrazolo-triazine and/or pyrazolo-pyrimidine derivatives | |
US2016324827A1 | Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation | |
WO2016166250A1 | Quinoline derivatives as tam rtk inhibitors | |
WO2015064898A1 | Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation |